Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Express Scripts
Baxter
Moodys

Last Updated: August 19, 2022

Investigational Drug Information for ASP0456


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for ASP0456?

ASP0456 is an investigational drug.

There have been 6 clinical trials for ASP0456. The most recent clinical trial was a Phase 3 trial, which was initiated on October 21st 2014.

The most common disease conditions in clinical trials are Constipation, Syndrome, and Irritable Bowel Syndrome. The leading clinical trial sponsors are Astellas Pharma Inc and [disabled in preview].

There are one hundred and eighty-seven US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for ASP0456
TitleSponsorPhase
A Study of Oral Dosing of ASP0456 in Patients With Chronic ConstipationAstellas Pharma IncPhase 3
A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic ConstipationAstellas Pharma IncPhase 2
Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel SyndromeAstellas Pharma IncPhase 3

See all ASP0456 clinical trials

Clinical Trial Summary for ASP0456

Top disease conditions for ASP0456
Top clinical trial sponsors for ASP0456

See all ASP0456 clinical trials

US Patents for ASP0456

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
ASP0456 See Plans and Pricing Ultra-pure agonists of guanylate cyclase C, method of making and using same SYNERGY PHARMACEUTICALS, INC. (New York, NY) See Plans and Pricing
ASP0456 See Plans and Pricing Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide Alkermes, Inc. (Waltham, MA) See Plans and Pricing
ASP0456 See Plans and Pricing Formulations of guanylate cyclase C agonists and methods of use SYNERGY PHARMACEUTICALS, INC. (New York, NY) See Plans and Pricing
ASP0456 See Plans and Pricing Benzazole compounds and methods for making and using the compounds Rigel Pharmaceuticals, Inc. (South San Francisco, CA) See Plans and Pricing
ASP0456 See Plans and Pricing Compositions and methods for inducing urinary voiding and defecation Dignify Therapeutics, LLC (Research Triangle Park, NC) See Plans and Pricing
ASP0456 See Plans and Pricing Method for treating constipation GELESIS LLC (Boston, MA) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for ASP0456

Drugname Country Document Number Estimated Expiration Related US Patent
ASP0456 Australia AU2014274812 2033-06-05 See Plans and Pricing
ASP0456 Australia AU2018226473 2033-06-05 See Plans and Pricing
ASP0456 Australia AU2020205349 2033-06-05 See Plans and Pricing
ASP0456 Canada CA2913737 2033-06-05 See Plans and Pricing
ASP0456 China CN105764916 2033-06-05 See Plans and Pricing
ASP0456 China CN113388007 2033-06-05 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Johnson and Johnson
Express Scripts
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.